โšกToday
โœจToday's leadSea Turtle Hatchlings From the West Coast's First Known Natural Nests Return to the Wild๐ŸŽˆFor kidsBaby sea turtles hatch and swim out from California's first recorded nests๐ŸŒฟNatureSouth Carolina tract beside wildlife refuge to be permanently conservedโšฝSportsLindy Duncan wins her first LPGA title on attempt 222๐ŸŽจCulture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately Held๐Ÿ”ฌScience & healthDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease๐Ÿ’›KindnessNine-year-old makes comfort bags for lost kids with autism๐Ÿ›๏ธPoliticsAllegheny County passes 12 weeks of paid parental leave๐Ÿš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

Bladder cancer immunotherapy cuts tumor recurrence risk by 68%

STAT 16 November 2026 2 min read

โฎ BeforeBladder cancer tumors often return after treatment.
โœ… NowAn immunotherapy from CG Oncology reduced that risk by 68 percent in reported results.

In short

  • CG Oncology's bladder cancer immunotherapy reduced the risk of tumor recurrence by 68%.
  • The results may change how physicians treat certain patients.
  • The source gives no trial size or stage details.

Why it's good news

Recurrence is one of the hardest parts of bladder cancer to manage, because patients need repeated monitoring and procedures. A 68 percent reduction in risk, if it holds, would change treatment choices for some patients. The source is brief, so the size of the study and its stage should be checked in the full report.

Advertisement

From STAT

CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% โ€” results that may change how physicians treat certain patients.

Read the full story at STAT Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

Next in today's ten

Advertisement
AdMobile anchor